Profile | GDS4284 / 213945_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 548.127 | 65 |
GSM687648 | Patient 402 control | 391.506 | 60 |
GSM687653 | Patient 403 control | 556.11 | 66 |
GSM687658 | Patient 404 control | 404.89 | 60 |
GSM687663 | Patient 411 control | 417.059 | 60 |
GSM687668 | Patient 422 control | 613.54 | 67 |
GSM687673 | Patient 424 control | 558.891 | 65 |
GSM687678 | Patient 425 control | 425.414 | 60 |
GSM687683 | Patient 427 control | 430.593 | 60 |
GSM687688 | Patient 428 control | 443.255 | 62 |
GSM687695 | Patient 441 control | 1028.84 | 76 |
GSM687699 | Patient 443 control | 475.524 | 62 |
GSM687704 | Patient 444 control | 538.706 | 65 |
GSM687707 | Patient 448 control | 755.463 | 70 |
GSM687712 | Patient 449 control | 402.693 | 60 |
GSM687719 | Patient 450 control | 314.65 | 54 |
GSM687724 | Patient 451 control | 1041.14 | 75 |
GSM687728 | Patient 452 control | 378.283 | 59 |
GSM687646 | Patient 401 treated 24h | 359.553 | 58 |
GSM687649 | Patient 402 treated 24h | 225.468 | 52 |
GSM687665 | Patient 411 treated 24h | 413.794 | 60 |
GSM687651 | Patient 402 treated 4 weeks | 699.757 | 68 |
GSM687667 | Patient 411 treated 4 weeks | 516.729 | 64 |
GSM687670 | Patient 422 treated 24h | 291.301 | 54 |
GSM687671 | Patient 422 treated 4 weeks | 536.381 | 64 |
GSM687654 | Patient 403 treated 24h | 632.9 | 68 |
GSM687675 | Patient 424 treated 24h | 496.367 | 63 |
GSM687685 | Patient 427 treated 24h | 555.683 | 65 |
GSM687656 | Patient 403 treated 4 weeks | 396.638 | 61 |
GSM687677 | Patient 424 treated 4 weeks | 581.342 | 66 |
GSM687687 | Patient 427 treated 4 weeks | 298.121 | 56 |
GSM687692 | Patient 428 treated 4h | 555.059 | 65 |
GSM687716 | Patient 449 treated 4h | 560.174 | 66 |
GSM687722 | Patient 450 treated 4h | 529.459 | 63 |
GSM687680 | Patient 425 treated 24h | 410.933 | 60 |
GSM687690 | Patient 428 treated 24h | 868.449 | 72 |
GSM687700 | Patient 443 treated 24h | 478.234 | 60 |
GSM687705 | Patient 444 treated 24h | 375.487 | 60 |
GSM687714 | Patient 449 treated 24h | 296.924 | 56 |
GSM687721 | Patient 450 treated 24h | 343.392 | 55 |
GSM687682 | Patient 425 treated 4 weeks | 471.042 | 63 |
GSM687694 | Patient 428 treated 4 weeks | 455.164 | 62 |
GSM687702 | Patient 443 treated 4 weeks | 303.673 | 54 |
GSM687718 | Patient 449 treated 4 weeks | 421.221 | 61 |
GSM687723 | Patient 450 treated 4 weeks | 218.838 | 49 |
GSM687661 | Patient 404 treated 4h | 442.63 | 61 |
GSM687710 | Patient 448 treated 4h | 577.76 | 66 |
GSM687726 | Patient 451 treated 4h | 689.838 | 68 |
GSM687730 | Patient 452 treated 4h | 1821.59 | 84 |
GSM687660 | Patient 404 treated 24h | 375.08 | 58 |
GSM687697 | Patient 441 treated 24h | 611.484 | 66 |
GSM687709 | Patient 448 treated 24h | 696.837 | 69 |
GSM687725 | Patient 451 treated 24h | 600.63 | 66 |
GSM687729 | Patient 452 treated 24h | 533.003 | 65 |
GSM687727 | Patient 451 treated 4 weeks | 890.216 | 72 |
GSM687731 | Patient 452 treated 4 weeks | 545.211 | 64 |